These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27666194)

  • 1. Structural studies of Mycobacterium tuberculosis DprE1 interacting with its inhibitors.
    Piton J; Foo CS; Cole ST
    Drug Discov Today; 2017 Mar; 22(3):526-533. PubMed ID: 27666194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
    Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DprE1--from the discovery to the promising tuberculosis drug target.
    Mikusová K; Makarov V; Neres J
    Curr Pharm Des; 2014; 20(27):4379-403. PubMed ID: 24245764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis.
    Chikhale RV; Barmade MA; Murumkar PR; Yadav MR
    J Med Chem; 2018 Oct; 61(19):8563-8593. PubMed ID: 29851474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.
    Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1.
    Neres J; Hartkoorn RC; Chiarelli LR; Gadupudi R; Pasca MR; Mori G; Venturelli A; Savina S; Makarov V; Kolly GS; Molteni E; Binda C; Dhar N; Ferrari S; Brodin P; Delorme V; Landry V; de Jesus Lopes Ribeiro AL; Farina D; Saxena P; Pojer F; Carta A; Luciani R; Porta A; Zanoni G; De Rossi E; Costi MP; Riccardi G; Cole ST
    ACS Chem Biol; 2015 Mar; 10(3):705-14. PubMed ID: 25427196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
    Liu L; Kong C; Fumagalli M; Savková K; Xu Y; Huszár S; Sammartino JC; Fan D; Chiarelli LR; Mikušová K; Sun Z; Qiao C
    Eur J Med Chem; 2020 Dec; 208():112773. PubMed ID: 32898793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors.
    Balabon O; Pitta E; Rogacki MK; Meiler E; Casanueva R; Guijarro L; Huss S; Lopez-Roman EM; Santos-Villarejo Á; Augustyns K; Ballell L; Aguirre DB; Bates RH; Cunningham F; Cacho M; Van der Veken P
    J Med Chem; 2020 May; 63(10):5367-5386. PubMed ID: 32342688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the development of DprE1 inhibitors using AI/CADD approaches.
    Chen K; Xu R; Hu X; Li D; Hou T; Kang Y
    Drug Discov Today; 2024 Jun; 29(6):103987. PubMed ID: 38670256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1.
    Richter A; Rudolph I; Möllmann U; Voigt K; Chung CW; Singh OMP; Rees M; Mendoza-Losana A; Bates R; Ballell L; Batt S; Veerapen N; Fütterer K; Besra G; Imming P; Argyrou A
    Sci Rep; 2018 Sep; 8(1):13473. PubMed ID: 30194385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization.
    Brecik M; Centárová I; Mukherjee R; Kolly GS; Huszár S; Bobovská A; Kilacsková E; Mokošová V; Svetlíková Z; Šarkan M; Neres J; Korduláková J; Cole ST; Mikušová K
    ACS Chem Biol; 2015 Jul; 10(7):1631-6. PubMed ID: 25906160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual Screening of Small Molecular Inhibitors against DprE1.
    Zhang G; Guo S; Cui H; Qi J
    Molecules; 2018 Feb; 23(3):. PubMed ID: 29495447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 2-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)amino)-N-phenylpropanamides as a novel class of potent DprE1 inhibitors.
    Whitehurst BC; Young RJ; Burley GA; Cacho M; Torres P; Vela-Gonzalez Del Peral L
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127192. PubMed ID: 32312582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1.
    Trefzer C; Škovierová H; Buroni S; Bobovská A; Nenci S; Molteni E; Pojer F; Pasca MR; Makarov V; Cole ST; Riccardi G; Mikušová K; Johnsson K
    J Am Chem Soc; 2012 Jan; 134(2):912-5. PubMed ID: 22188377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic molecules as DprE1 inhibitors: A patent review.
    Imran M; A S A; Thabet HK; Abida ; Afroz Bakht M
    Expert Opin Ther Pat; 2021 Aug; 31(8):759-772. PubMed ID: 33709862
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Borthwick JA; Alemparte C; Wall I; Whitehurst BC; Argyrou A; Burley G; de Dios-Anton P; Guijarro L; Monteiro MC; Ortega F; Suckling CJ; Pichel JC; Cacho M; Young RJ
    J Med Chem; 2020 Mar; 63(5):2557-2576. PubMed ID: 31922409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.
    Bhutani I; Loharch S; Gupta P; Madathil R; Parkesh R
    PLoS One; 2015; 10(3):e0119771. PubMed ID: 25789990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors.
    Rogacki MK; Pitta E; Balabon O; Huss S; Lopez-Roman EM; Argyrou A; Blanco-Ruano D; Cacho M; Vande Velde CML; Augustyns K; Ballell L; Barros D; Bates RH; Cunningham F; Van der Veken P
    J Med Chem; 2018 Dec; 61(24):11221-11249. PubMed ID: 30500189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent Benzothiazinone Analogues Efficiently and Selectively Label Dpre1 in Mycobacteria and Actinobacteria.
    Sommer R; Neres J; Piton J; Dhar N; van der Sar A; Mukherjee R; Laroche T; Dyson PJ; McKinney JD; Bitter W; Makarov V; Cole ST
    ACS Chem Biol; 2018 Nov; 13(11):3184-3192. PubMed ID: 30289689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship mediated molecular insights of DprE1 inhibitors: A Comprehensive Review.
    Dash S; Rathi E; Kumar A; Chawla K; Joseph A; Kini SG
    J Biomol Struct Dyn; 2024 Aug; 42(12):6472-6522. PubMed ID: 37395797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.